Achilles Therapeutics plc (ACHL)
USD 0.97
(-0.22%)
USD 0.97
(-0.22%)
| Breakdown | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 4.73 Million | 3.68 Million | 3.28 Million | 778 Thousand | 303.25 Thousand | - |
| Gross Profit | -4.73 Million | -3.68 Million | -3.28 Million | -778 Thousand | -303.25 Thousand | - |
| Operating Expenses | 75.25 Million | 78.38 Million | 64.19 Million | 33.72 Million | 13.77 Million | 6.88 Million |
| Selling, General and Administrative Expenses | 17 Million | 21.12 Million | 21.97 Million | 11.09 Million | 4.7 Million | 2.09 Million |
| Research and Development Expenses | 67.64 Million | 57.26 Million | 42.22 Million | 22.62 Million | 9.07 Million | 4.8 Million |
| Other Expenses | -9.4 Million | 7.31 Million | 3.13 Million | 531 Thousand | -215 Thousand | - |
| Cost and Expenses | 75.25 Million | 78.38 Million | 64.19 Million | 33.72 Million | 13.77 Million | 6.88 Million |
| Operating Income | -75.25 Million | -78.38 Million | -64.19 Million | -33.72 Million | -13.77 Million | -6.9 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 491 Thousand | 111 Thousand | 37 Thousand | 3000.00 | 130.14 Thousand | - |
| Earnings before Tax | -69.17 Million | -71.06 Million | -61.06 Million | -33.19 Million | -13.99 Million | -6.88 Million |
| Net Income | -69.66 Million | -71.17 Million | -61.09 Million | -33.19 Million | -13.99 Million | -6.88 Million |
| Earnings Per Share Basic | -1.74 | -1.82 | -2.13 | -0.82 | -8.52 | -12.71 |
| Earnings Per Share Diluted | -1.74 | -1.82 | -2.13 | -0.82 | -8.52 | -12.69 |
| Weighted Average Shares Outstanding | 39.97 Million | 39.13 Million | 28.65 Million | 40.62 Million | 1.64 Million | 542 Thousand |
| Weighted Average Shares Outstanding (Diluted) | 39.97 Million | 39.13 Million | 28.65 Million | 40.62 Million | 1.64 Million | 542.58 Thousand |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -70.44 Million | -78.38 Million | -57.76 Million | -32.95 Million | -13.47 Million | -6.72 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
| Breakdown | 2024 Q2 | 2024 Q1 | 2023 FY | 2023 Q4 | 2023 Q3 | 2023 Q2 |
|---|---|---|---|---|---|---|
| Revenue | - | - | - | - | - | - |
| Cost of Revenue | 1.17 Million | 1.17 Million | 4.73 Million | 1.15 Million | 1.19 Million | 1.3 Million |
| Gross Profit | -1.17 Million | -1.17 Million | -4.73 Million | -1.15 Million | -1.19 Million | -1.3 Million |
| Operating Expenses | 16.64 Million | 13.11 Million | 80.25 Million | 18.52 Million | 19.09 Million | 18.09 Million |
| Selling, General and Administrative Expenses | 2.99 Million | 2.97 Million | - | 2.49 Million | 4.38 Million | 4.31 Million |
| Research and Development Expenses | 13.65 Million | 10.13 Million | - | 16.03 Million | 14.71 Million | 13.77 Million |
| Other Expenses | 1.42 Million | 2 Million | - | 1.38 Million | 2.38 Million | 1.21 Million |
| Cost and Expenses | 17.81 Million | 14.29 Million | 84.98 Million | 19.68 Million | 19.09 Million | 18.09 Million |
| Operating Income | -17.81 Million | -14.29 Million | -84.98 Million | -19.68 Million | -19.09 Million | -18.09 Million |
| Interest Expense | - | - | - | - | - | - |
| Income Tax Expense | 8008.97 | -22.98 Thousand | -8.94 Million | 509.39 Thousand | -24 Thousand | -34 Thousand |
| Earnings before Tax | -16.39 Million | -12.28 Million | -78.87 Million | -18.28 Million | -16.7 Million | -16.88 Million |
| Net Income | -16.39 Million | -12.26 Million | -69.93 Million | -18.79 Million | -16.68 Million | -16.84 Million |
| Earnings Per Share Basic | -0.41 | -0.30 | - | -0.47 | -0.42 | -0.42 |
| Earnings Per Share Diluted | -0.41 | -0.30 | - | -0.47 | -0.42 | -0.42 |
| Weighted Average Shares Outstanding | 40.35 Million | 40.28 Million | 39.97 Million | 40.18 Million | 40.06 Million | 39.89 Million |
| Weighted Average Shares Outstanding (Diluted) | 40.35 Million | 40.28 Million | 39.97 Million | 40.18 Million | 40.06 Million | 39.89 Million |
| Gross Margin | - | - | - | - | - | - |
| EBIT Margin | - | - | - | - | - | - |
| Profit Margin | - | - | - | - | - | - |
| EBITDA | -16.64 Million | -13.11 Million | - | -18.52 Million | -19.09 Million | -18.09 Million |
| Earnings Before Tax Margin | - | - | - | - | - | - |
092780
8946
600875
688009
1777
PAB